Pasteurellosis in sheep and goats; cause, symptom, treatment and prevention

  • Home
  • Ethiopia
  • Adama
  • Pasteurellosis in sheep and goats; cause, symptom, treatment and prevention

Pasteurellosis in sheep and goats; cause, symptom, treatment and prevention The systemic form of pasteurellosis caused by B trehalosi is characterized by fever, listlessness, p Death losses are high in severely affected animals.

Etiology and Pathogenesis:
M haemolytica and B trehalosi are distributed worldwide, and diseases caused by them are common in sheep and goats of all ages, although the prevalence of serotypes may vary by region and flock. M haemolytica, B trehalosi, and P multocida are common commensal organisms of the tonsils and nasopharynx of healthy sheep and goats. The presence of multiple Pasteurella spp may

serve to keep the bacterial populations in check, because there appears to be some interference with growth when multiple species are present. For these organisms to cause infection, a combination of stressors, including heat, overcrowding, exposure to inclement weather, poor ventilation, handling, and transportation, leaves sheep and goats susceptible to respiratory viral infections. Parainfluenza 3, adenovirus type 6, respiratory syncytial virus, possibly bovine adenovirus type 2, ovine adenovirus types 1 and 5, and reovirus type 1 cause primary respiratory infections that are rarely life threatening but predispose to secondary M haemolytica infections. Respiratory infections with Mycoplasma ovipneumoniae and Bordetella parapertussis have also been reported to be associated with secondary M haemolytica infections. The combination of stressors and primary infections are thought to break down the mucosal barrier integrity of the lower respiratory tract, allowing M haemolytica to colonize, proliferate, and induce significant tissue damage. The virulence of M haemolytica and B trehalosi is mediated by the action of several factors, including endotoxin, leukotoxin, and capsular polysaccharide, that afford the bacteria advantages over host immunity. The leukotoxin is particularly important in the pathogenesis, because it is specifically toxic to ruminant leukocytes, resulting in fibrin deposition in lungs and on pleural surfaces. The lipopolysaccharide endotoxin contributes to adverse reactions in the lungs and also leads to systemic circulatory failure and shock. The capsular polysaccharide prevents the phagocytosis of the bacteria and assists in attachment to the alveolar epithelial surface. Survival of the acute phase of pneumonic pasteurellosis depends on the extent of lung involvement and damage in the lower respiratory tract. Sheep and goats that recover may have chronic respiratory problems, including reduced lung capacity and weight gain efficiency if ≥20% of the lung was damaged. In one review, there was no association between virulence and the presence of hemolysis on blood agar culture plates. Clinical Findings and Lesions:
B trehalosi mainly causes septicemia and systemic pasteurellosis in sheep

Prevention of Pasteurellosis of Sheep and GoatsPasteurellosis prevention would be desirable given the economic costs of ...
28/09/2022

Prevention of Pasteurellosis of Sheep and Goats
Pasteurellosis prevention would be desirable given the economic costs of treatment, losses, and reduction of weight gain in survivors. Avoidance or reduction of known stressors such as heat, overcrowding, exposure to inclement weather, poor ventilation, handling, nutritional problems, transportation, and commingling is a primary consideration for prevention of disease. Inclusion of metaphylactic antimicrobial treatment, mainly with tetracycline, during the months of the year with the highest incidence of pasteurellosis is a common management practice.

A vaccination program to prevent respiratory virus infection would be expected to decrease the incidence of respiratory pasteurellosis by avoiding the initial insult that allows colonization.

There are no commercial vaccines against pasteurellosis organisms in the US; producers can obtain autogenous bacterins for their flocks, but evidence that these are efficacious is anecdotal. Commercial vaccines are available for cattle but unfortunately are specific for M haemolytica A1, and there is little or no cross-protection against M haemolytica A2 experimentally. Commercial vaccines for M haemolytica A2 are available in the UK and have been reported to be beneficial in reducing death losses and increasing weight gains from both septicemic and pneumonic forms of pasteurellosis. An intranasal recombinant vaccine has protected lambs challenged with P multocida; however, this vaccine is not commercially available.

Treatment of Pasteurellosis of Sheep and GoatsAntimicrobial treatmentAncillary anti-inflammatory treatmentsMetaphylaxis ...
28/09/2022

Treatment of Pasteurellosis of Sheep and Goats
Antimicrobial treatment
Ancillary anti-inflammatory treatments
Metaphylaxis of high-risk populations
Early identification of respiratory disease and introduction of effective antimicrobial treatment is necessary. Antimicrobial treatment typically consists of long-acting tetracyclines, broad-spectrum beta-lactam antimicrobials, macrolides, or florfenicol. Bacteriologic culture and antimicrobial susceptibility testing of clinical isolates may be indicated to direct antimicrobial treatment. Antimicrobial susceptibility patterns of M haemolytica, B trehalosi, and P multocida have shown resistance to penicillins (all three organisms), sulfadimethoxine (P multocida), and tetracyclines (B trehalosi and occasionally M haemolytica), although tetracycline resistance is less prevalent in small ruminant disease than that in cattle. Ampicillin, ceftiofur, danofloxacin, florfenicol, trimethoprim-sulfamethoxazole, tilmicosin (in sheep), and tulathromycin would be expected to have good efficacy. Although enrofloxacin is likely efficacious, in the US it is not labeled for use in small ruminants, and fluoroquinolones are expressly prohibited from extralabel use.
Treatment is frequently unrewarding unless begun early in the disease process because of rapid progression of lung damage and endotoxin release.
Parenteral fluids and anti-inflammatory agents are potential adjuncts to antimicrobial treatment. Ancillary anti-inflammatory treatments (eg, flunixin or dexamethasone) are often used but not well supported by the literature. Although NSAIDs specifically are appropriate in the face of endotoxemia, there is no consensus on efficacy for improved clinical outcomes in small ruminant pasteurellosis and little positive evidence when used for bovine respiratory disease. Corticosteroids are not indicated in small ruminant pasteurellosis. Although septicemic pasteurellosis has favorable antimicrobial susceptibility, response to treatment is often disappointing.
Administering antimicrobials to at-risk lambs prophylactically may be beneficial.

Pasteurella and Mannheimia organisms are beta-hemolytic, gram-negative, aerobic, nonmotile, non–spore-forming coccobacil...
28/09/2022

Pasteurella and Mannheimia organisms are beta-hemolytic, gram-negative, aerobic, nonmotile, non–spore-forming coccobacilli in the family Pasteurellaceae. This family tends to inhabit the mucosal surfaces of the GI, respiratory, and ge***al tracts of mammals. Many are known as opportunistic secondary invaders. Some species show preferences for specific surfaces and hosts.
Updating of phylogenetic data has resulted in renaming based on gene sequence analysis. As a result, Pasteurella haemolytica biotypes A and T have been reclassified as Mannheimia haemolytica (biotype A) and Pasteurella trehalosi (biotype T). More recently, P trehalosi has been reclassified as Bibersteinia trehalosi.
Each isolate of M haemolytica and B trehalosi is designated with a biotype and serotype. The most common strain isolated from sheep and goat respiratory pasteurellosis is M haemolytica A2, although A6, A13, and Ant have been reported in sheep, as has Ant in goats. Additionally, M haemolytica A2 is routinely reported from cases of mastitis in sheep. Bibersteinia trehalosi T3, T4, T10, and T15 have been most often associated with the systemic or septicemic form of pasteurellosis affecting lambs. These serotypes have been regrouped to B trehalosi biotype 2, and a new biotype 4 has been added.
Both M haemolytica and B trehalosi are distributed worldwide, and the diseases they cause are common in sheep and goats of all ages, although the prevalence of serotypes may vary by region and flock. Mannheimia haemolytica, B trehalosi, and P multocida are common commensal organisms of the tonsils and nasopharynx of healthy sheep and goats. The presence of multiple Pasteurella spp may serve to keep the bacterial populations in check, given that there appears to be some interference with growth when multiple species are present.
For these organisms to cause infection, a combination of stressors, including heat, overcrowding, exposure to inclement weather, poor ventilation, handling, and transportation, leaves sheep and goats susceptible to respiratory viral infections. Parainfluenza 3, adenovirus type 6, respiratory syncytial virus, possibly bovine adenovirus type 2, ovine adenovirus types 1 and 5, and reovirus type 1 cause primary respiratory infections that are rarely life-threatening but predispose sheep and goats to secondary M haemolytica infections. Respiratory infections with Mycoplasma ovipneumoniae and Bordetella parapertussis have also been reported to be associated with secondary M haemolytica infections. The combination of stressors and primary infections is thought to break down the mucosal barrier integrity of the lower respiratory tract, allowing M haemolytica to colonize, proliferate, and induce tissue damage.
The virulence of M haemolytica and B trehalosi is mediated by the action of several factors, including endotoxin, leukotoxin, and capsular polysaccharide, which afford the bacteria advantages over host immunity. The leukotoxin is particularly important in the pathogenesis because it is specifically toxic to ruminant leukocytes, resulting in fibrin deposition in lungs and on pleural surfaces. The lipopolysaccharide endotoxin contributes to adverse reactions in the lungs and also leads to systemic circulatory failure and shock. The capsular polysaccharide prevents the phagocytosis of the bacteria and assists in attachment to the alveolar epithelial surface.
Survival of the acute phase of pneumonic pasteurellosis depends on the extent of lung involvement and damage in the lower respiratory tract. Sheep and goats that recover may have chronic respiratory problems, including decreased lung capacity and weight gain efficiency if ≥20% of the lung was damaged. In one review, there was no association between virulence and the presence of hemolysis on blood agar culture plates

28/09/2022

The uptake of vaccines to provide protection to sheep from pasteurellosis follows a similar trend to that of clostridial vaccines. This is not surprising, given that the main vaccines used are combination clostridia–pasteurellosis vaccines. Pasteurella vaccine uptake has been steady over the past six years, with close to half of all sheep being vaccinated (46–51%).

Pasteurellosis is caused by two common bacteria: Bibersteinia trehalosi and Mannheimia haemolytica and typically causes ...
31/08/2022

Pasteurellosis is caused by two common bacteria: Bibersteinia trehalosi and Mannheimia haemolytica and typically causes pneumonia and death. young and store lambs are at highest risk of infection however sheep of all ages are at risk. The bacteria are carried by healthy sheep and disease is triggered by various stress factors:
Diet changes
Handling
Drenching
Bad weather, or weather changes
Weaning
Shearing
Transport
Lambing
Other disease e.g. worms & fluke
Housing
Antibiotics will treat pasteurellosis if they are found early enough but as sudden death is often the first sign of disease antibiotics will not always be an option
Careful management can help to reduce stress, but stress cannot be avoided completely. Good planning is essential; try to ensure you handle your sheep as little as possible.
Vaccination is the most effective way of preventing pasteurellosis and preventing related losses. There is a wide range of vaccines available and they are good value and cost effective.

05/08/2022

Pasteurellosis
Pasteurellosis is of considerable economic importance to the sheep industry and according to NADIS it was the most common cause of sudden death in lamb in the UK between August and December 2016.
Pasteurellosis is caused by two common bacteria: Bibersteinia trehalosi and Mannheimia haemolytica and typically causes pneumonia and death. young and store lambs are at highest risk of infection however sheep of all ages are at risk. The bacteria are carried by healthy sheep and disease is triggered by various stress factors:
Diet changes
Handling
Drenching
Bad weather, or weather changes
Weaning
Shearing
Transport
Lambing
Other disease e.g. worms & fluke
Housing
Antibiotics will treat pasteurellosis if they are found early enough but as sudden death is often the first sign of disease antibiotics will not always be an option
Careful management can help to reduce stress, but stress cannot be avoided completely. Good planning is essential; try to ensure you handle your sheep as little as possible.
Vaccination is the most effective way of preventing pasteurellosis and preventing related losses. There is a wide range of vaccines available and they are good value and cost effective.

05/08/2022

Respiratory disease is common in sheep and goats and is usually the result of a series of complicated interactions involving stress inducers, both physical and physiological, and a variety of infectious agents. The most common form of respiratory disease is pasteurellosis. In lambs and kids affected with the acute disease the signs include fever, dyspnoea, anorexia, recumbence and sudden death. If the animals survive they can become chronically affected with resultant reduced ability to thrive and survive further infections. 2 Pasteurellosis can therefore have a significant impact on the productive efficacy of small stock.
Although the main clinical form of pasteurellosis in sheep and goats is pneumonia there is also a systemic form found only in sheep. The pneumonic form is caused by Mannheimia haemolytica (formerly designated Pasteurella haemolytica1 (see below for more details), and the systemic disease by Bibersteinia trehalosi. In sheep in temperate climates Pasteurella multocida rarely causes pneumonia and little is known of the epidemiology of that infection. Pasteurellosis caused by M. haemolytica is one of the most common bacterial infections of sheep and goats, and by far the most important respiratory one, with a widespread distribution, occurring in temperate, subtropical and tropical climates.7, 11, 15, 21
Aetiology
Pneumonic pasteurellosis in sheep was first described in 19316 but it was not until the 1960s that serotyping and biotyping helped to define the epidemiology of the disease. In sheep, two ‘Pasteurella’ species, M. haemolytica and P. trehalosi, share a common serotyping system comprising a total of 17 serotypes,1, 17, 20 with approximately 90 per cent of all isolates serotypable. Each of the two species, originally biotypes of Mannheimia haemolytica, is associated with a distinct clinical syndrome. M. haemolytica (formerly biotype A) strains are responsible for pneumonic pasteurellosis in sheep and goats of all ages while P. trehalosi strains (formerly biotype T) cause a systemic disease in six to ten-month-old lambs.8
In 1999 the taxonomy of the family Pasteurellaceae changed in response to new information on the relatedness of strains following studies on DNA and ribosomal RNA homology. 1 The revised taxonomy introduced a new genus, Mannheimia, to replace Pasteurella haemolytica and P. haemolytica-like strains. The prototype species of the new genus is Mannheimia haemolytica, which includes all the former P. haemolytica A serotype strains apart from A11. Strains of this latter serotype are now placed in another Mannheimia species,M. glucosida.
The three species are divided into 17 serotypes on the basis of an indirect haemagglutination test, which depends on the serotypes having specific polysaccharide capsules. Serotypes 1, 2, 5, 6, 7, 8, 9, 12, 13, 14, 16 and 17 belong to M. haemolytica, A11 is now M. glucosida and serotypes 3, 4, 10 and 15 areP. trehalosi. The taxonomy of P. trehalosi remains unchanged. The main characteristics of all the new Mannheimia spp. are shown in and a more detailed list of differences between Mannheimia and Pasteurella spp. is shown
A summary of the changes affecting M. haemolytica and P. trehalosi serotyping is shown
Mannheimia haemolytica and P. trehalosi are identical in their morphology both being encapsulated, small (1–2mm× 0,3–0,6 mm), Gram-negative, aerobic coccobacilli. In carbohydrate fermentation tests it was originally thought that strains of M. haemolytica fermented arabinose (hence the former biotype A designation) but not trehalose, whereas all P. trehalosi strains ferment trehalose (hence the former biotype T designation). Colonies of M. haemolytica are small and grey with a narrow zone of haemolysis after 24 hours’ incubation. The colonies of P. trehalosi strains are darker, larger (up to 3mm in diameter) and have brownish centres.

09/05/2022

Pasteurellosis
Pasteurellosis is of considerable economic importance to the UK sheep industry and according to NADIS it was the most common cause of sudden death in lamb in the UK between August and December 2016.
Pasteurellosis is caused by two common bacteria: Bibersteinia trehalosi and Mannheimia haemolytica and typically causes pneumonia and death. young and store lambs are at highest risk of infection however sheep of all ages are at risk. The bacteria are carried by healthy sheep and disease is triggered by various stress factors:
Diet changes
Handling
Drenching
Bad weather, or weather changes
Weaning
Shearing
Transport
Lambing
Other disease e.g. worms & fluke
Housing
Antibiotics will treat pasteurellosis if they are found early enough but as sudden death is often the first sign of disease antibiotics will not always be an option
Careful management can help to reduce stress, but stress cannot be avoided completely. Good planning is essential; try to ensure you handle your sheep as little as possible.
Vaccination is the most effective way of preventing pasteurellosis and preventing related losses. There is a wide range of vaccines available and they are good value and cost effective.

Address

Adama
1000

Telephone

+251968485345

Website

Alerts

Be the first to know and let us send you an email when Pasteurellosis in sheep and goats; cause, symptom, treatment and prevention posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Pasteurellosis in sheep and goats; cause, symptom, treatment and prevention:

Shortcuts

Share

Category